Search

everythinglearnresearchcommunity

for

Search:↓

Allopregnanolone increases KCC2 expression in baby male rats' brains, while finasteride doesn't affect it.

Skin side effects from cancer drugs targeting EGFR can affect treatment adherence but can be managed with antibiotics like tetracycline.

Neuroactive steroids show promise for treating mental and neurological disorders by targeting GABA_A receptors.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

PCOS is a complex condition in women that can lead to health issues, and lifestyle changes are the best management approach.

Finasteride treatment changes brain steroid levels and receptors, affecting brain function even after stopping treatment.

Clinicians should use social and prescription data to track trends in performance-enhancing drug use.

Some people experience lasting sexual, psychological, and sleep problems after using finasteride or SSRI antidepressants, possibly due to similar underlying causes.

Many women who have used performance-enhancing drugs in Finland show high rates of mental health and substance use issues, and most have normal red blood cell counts.

Younger patients and those with more hair loss are less likely to benefit from oral steroid treatment for hair loss, and low vitamin D may predict relapse.

A new green method accurately measures finasteride and tadalafil in drugs and plasma.

New targets for making and using brain-synthesized steroids could lead to better treatments for brain disorders and alcoholism.

New signs like changes in blood markers, physical symptoms, and behavioral shifts may help detect hidden steroid use in athletes.

Lecithin organogels could be good for applying drugs to the skin because they are stable, safe, and can improve drug absorption.

Transplant success has improved with better immunosuppressive drugs and donor matching.

The congress concluded that misuse of antifungal drugs in South Asia has led to widespread treatment failure, and new approaches and regional cooperation are needed.

Simvastatin may help manage symptoms in women with non-classic congenital adrenal hyperplasia by lowering cholesterol and certain hormone levels.

Tyrosine kinase inhibitors show promise in treating some skin diseases but their definitive role in dermatology is still unclear.

Nanostructured delivery systems could potentially improve hair loss treatment by targeting drugs to hair follicles, reducing side effects and dosage, but the best size, charge, and materials for these systems need further investigation.

Both treatments for alopecia areata showed similar modest effectiveness.

The document concludes that validated methods are needed to ensure the quality of fluconazole drugs and that new antifungal medications are necessary due to safety and resistance concerns.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

New nanocarriers improve skin drug delivery with low toxicity at certain concentrations.

Mexican medicinal plants are used to treat hair loss.

EGFR inhibitors often cause skin problems and other side effects, but these are usually reversible and can be managed to keep patients comfortable.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.

Certain medications, especially 5-α reductase inhibitors and neuropsychiatric drugs, are often linked to erectile dysfunction.

PCOS management includes lifestyle changes and medications, with ongoing research into repurposed drugs for better treatment options.

Men with higher androgen levels may have severe COVID-19 symptoms, but those on antiandrogen therapy are less likely to contract the virus and have milder symptoms. Anti-androgen drugs could potentially treat COVID-19, but more research is needed.

Triamcinolone regrows hair better but relapses more than anthralin.